A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a "game-changer" and ...

First breakthrough in treating asthma attacks in 50 years hailed as a ‘game-changer’ - Benralizumab is a monoclonal antibody ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

First new treatment for asthma attacks in 50 years is 30 per cent more effective than steroid tablets, UK scientists find ...

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...

The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

A clinical trial of the drug benralizumab showed it was far more effective than conventional steroid tablets at treating life-threatening breathing difficulties in people with a severe form of the ...

Benralizumab, a monoclonal antibody, is the first breakthrough in asthma and COPD flare-up treatment in 50 years. Targeting ...

Eupraxia Pharmaceuticals' shares rose after the clinical-stage biotechnology company reported positive data from its Eosinophilic Esophagitis program, which it believes underscore its DiffuSphere ...

The following is a summary of “Effect of Mepolizumab in airway’s remodelling in patients with late-onset severe asthma with ...